Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P G Pappas

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Antimicrobial Agents and Chemotherapy|October 16, 2001
Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998M E Brandt, M A Pfaller, R A Hajjeh, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 3, 2012
Pneumocystis pneumonia in hospitalized patients: a detailed examination of symptoms, management, and outcomes in human immunodeficiency virus (HIV)-infected and HIV-uninfected personsJ A McKinnell, A P Cannella, D F Kunz, et al.
Infectious Diseases and Therapy|June 18, 2022
Multicenter Registry of Patients Receiving Systemic Mold-Active Triazoles for the Management of Invasive Fungal InfectionsL Ostrosky-Zeichner, M H Nguyen, J Bubalo, et al.
Antimicrobial Agents and Chemotherapy|March 28, 2012
Safety and tolerability of voriconazole in patients with baseline renal insufficiency and candidemiaA M L Oude Lashof, J D Sobel, M Ruhnke, et al.
Diagnostic Microbiology and Infectious Disease|February 1, 1994
Comparative analysis of three antifungal susceptibility test methods against prospectively collected Candida speciesK M Villareal, R A Cook, J N Galgiani, et al.
Annals of Epidemiology|May 20, 1998
Surveillance of cryptococcosis in Alabama, 1992-1994C J Thomas, J Y Lee, L A Conn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 1996
Treatment of lymphocutaneous and visceral sporotrichosis with fluconazoleC A Kauffman, P G Pappas, D S McKinsey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2000
Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of AmericaM S Saag, R J Graybill, R A Larsen, et al.
Medical Mycology|August 23, 2005
Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance programJ Morgan, K A Wannemuehler, K A Marr, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1997
Treatment of blastomycosis with higher doses of fluconazole. The National Institute of Allergy and Infectious Diseases Mycoses Study GroupP G Pappas, R W Bradsher, C A Kauffman, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Antimicrobial Agents and Chemotherapy|October 16, 2001
Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998M E Brandt, M A Pfaller, R A Hajjeh, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 3, 2012
Pneumocystis pneumonia in hospitalized patients: a detailed examination of symptoms, management, and outcomes in human immunodeficiency virus (HIV)-infected and HIV-uninfected personsJ A McKinnell, A P Cannella, D F Kunz, et al.
Infectious Diseases and Therapy|June 18, 2022
Multicenter Registry of Patients Receiving Systemic Mold-Active Triazoles for the Management of Invasive Fungal InfectionsL Ostrosky-Zeichner, M H Nguyen, J Bubalo, et al.
Antimicrobial Agents and Chemotherapy|March 28, 2012
Safety and tolerability of voriconazole in patients with baseline renal insufficiency and candidemiaA M L Oude Lashof, J D Sobel, M Ruhnke, et al.
Diagnostic Microbiology and Infectious Disease|February 1, 1994
Comparative analysis of three antifungal susceptibility test methods against prospectively collected Candida speciesK M Villareal, R A Cook, J N Galgiani, et al.
Annals of Epidemiology|May 20, 1998
Surveillance of cryptococcosis in Alabama, 1992-1994C J Thomas, J Y Lee, L A Conn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 1996
Treatment of lymphocutaneous and visceral sporotrichosis with fluconazoleC A Kauffman, P G Pappas, D S McKinsey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2000
Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of AmericaM S Saag, R J Graybill, R A Larsen, et al.
Medical Mycology|August 23, 2005
Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance programJ Morgan, K A Wannemuehler, K A Marr, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1997
Treatment of blastomycosis with higher doses of fluconazole. The National Institute of Allergy and Infectious Diseases Mycoses Study GroupP G Pappas, R W Bradsher, C A Kauffman, et al.
Pageof 7